Protease-resistant peptide design-empowering nature's fragile warriors against HIV - Test2 - elhamkhani - TriplyDB

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

http://www.wikidata.org/entity/Q27010058

about

Improving binding affinity and stability of peptide ligands by substituting glycines with D-amino acids Viral membrane fusion.Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic pain Synthesis and folding of a mirror-image enzyme reveals ambidextrous chaperone activity.Peptides displayed as high density brush polymers resist proteolysis and retain bioactivity.Cancer cell surface induced peptide folding allows intracellular translocation of drug.Preferential germline usage and VH/VL pairing observed in human antibodies selected by mRNA display.Protein catalyzed capture agents with tailored performance for in vitro and in vivo applications.Peptide Backbone Composition and Protease Susceptibility: Impact of Modification Type, Position, and Tandem Substitution.Design of Stable α-Helical Peptides and Thermostable Proteins in Biotechnology and Biomedicine.Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders.Aligator: A computational tool for optimizing total chemical synthesis of large proteins.Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets.Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.Bike peptides: a ride through the membrane.N-Gemini peptides: cytosolic protease resistance via N-terminal dimerization of unstructured peptides.Short proline-rich lipopeptide potentiates minocycline and rifampicin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa.Pharmacokinetic and Chemical Synthesis Optimization of a Potent d-Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery.Characterization of the PEGylated Functional Upstream Domain Peptide (PEG-FUD): a Potent Fibronectin Assembly Inhibitor with Potential as an Anti-Fibrotic Therapeutic.Bulky Dehydroamino Acids Enhance Proteolytic Stability and Folding in β-Hairpin Peptides.

P2860

Q27685175-A32761A1-E14D-4EAA-8331-5D7743E44F0E Q28080422-EAB45CD8-1C10-40DA-9BF3-140417062944 Q33676679-49945258-BCC0-4020-81C5-0DA638A2B135 Q34060919-A5EA230D-F7B6-4801-AE5A-F3256B4409DD Q34489488-0CB7728D-AB49-4ADB-937B-3A891478F1F9 Q35691164-992A03FE-AA27-41EB-9055-F07B47627238 Q35763923-CCB5A182-AF55-4F05-AFF0-80523A1A6761 Q36107567-CDF3EF00-DC6B-443E-B05F-CBE022F2D8BD Q36488030-6EF7E973-2684-433A-8F2F-5807F1C4DBEC Q37544873-0DA9FF55-3236-4373-BAA0-95AF22774FBE Q38618616-2BA1973C-D199-46A6-AFB1-8F0F95F6F00D Q39148389-B923F0F8-5FA3-408D-A9E4-263AB734A29C Q39399243-4EEC6C28-4F84-489D-8AF0-D11A53C71BDD Q40188132-EAA8852E-F6F3-48EE-89C7-E54F909D88D3 Q41016131-E11FED94-1E52-4893-8587-DC9FAC8E2AD0 Q48112273-A4917ED2-4342-4071-BAA6-F0C1D3B17D28 Q48572712-A9FB1165-BDE8-4759-A0D2-2FFD0ACDAC48 Q50044323-5E516E22-15C0-41CD-8C86-B535589CAD8A Q50046992-1E0F808B-A97E-4A3A-A99C-D9412B28A6D5 Q52716966-1F4872C5-8F1C-4D64-8BEC-1B7F5E883EC6 Q53725826-C8BCE2B8-8042-4968-83FF-CFF8A79E73CB

P2860

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

http://www.wikidata.org/entity/Q27010058

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@ast

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@en

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@nl

type

label

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@ast

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@en

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@nl

prefLabel

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@ast

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@en

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@nl

P1433

Q27010058-C8E98C79-0BB0-4AFC-8F80-465294C8E5D6

P1476

Q27010058-FA4A7E88-8B0B-4ACF-B004-331F13DC6CFE

P2093

Q27010058-4069166A-B7A3-4DB7-8D0A-07A7D9789F8D

Q27010058-BCA547CA-4B80-4246-9ED7-5F806F86BA3D

Q27010058-DB6DDE08-C2D0-416D-B34B-A864338BAED3

Q27010058-FE325062-AF1B-40AA-A289-8BFFAECD1FC6

P2860

Q27010058-0144AAC0-2EE5-4929-8939-D43A9AA3E120

Q27010058-0157D237-7D15-47A6-B346-C872E7490308

Q27010058-020E42BE-E45F-46B2-ACA8-064974740385

Q27010058-0255AD7D-371E-4322-9BD6-53F8BEFD42C2

Q27010058-02DF4A20-444E-426A-8D01-93CDA45120E8

Q27010058-07708327-E9CB-40E2-AE62-A59957AA757C

Q27010058-07FD5789-4DDC-48A8-AE11-E0B4642F9801

Q27010058-080B611C-5543-4A1E-839A-2472562C82DD

Q27010058-0EB1613B-D94B-4D23-96A7-E0577BDD9309

Q27010058-15994F37-5B5A-45E2-8672-B111E3312BA5

P304

Q27010058-211035B1-F762-440A-880D-D7926F2AD2D7

P31

Q27010058-2010ffda-ed73-4249-ad0a-85f77e5b58c3

Q27010058-77EF6B8D-A66F-48FB-A7CC-5E84396B23E6

P356

Q27010058-A883DE00-88AE-45F0-8028-F2D1C40E20C4

P407

Q27010058-80DA1E88-D2E2-4D80-9D21-161FEC95E7D1

P433

Q27010058-6EA32DB4-4D99-40BE-A332-13F38BDF7715

P478

Q27010058-99D92E79-AFBE-4435-B0CF-330A4443CEE2

P577

Q27010058-57AD0B8A-BB25-41B6-BB66-BFB2997A2E67

P698

Q27010058-897B43B1-C830-4712-9B30-751159D732CF

P932

Q27010058-C6F0998B-E102-40F6-A395-4448EA26E7DF

P356

P1433

P1476

Protease-resistant peptide design-empowering nature's fragile warriors against HIV

@en

P2093

J. Nicholas Francis

http://www.w3.org/2001/XMLSchema#string

Joseph S. Redman

http://www.w3.org/2001/XMLSchema#string

Matthew T. Weinstock

http://www.w3.org/2001/XMLSchema#string

Michael S. Kay

http://www.w3.org/2001/XMLSchema#string

P2860

An expanded set of amino acid analogs for the ribosomal translation of unnatural peptides

Total chemical synthesis of proteins

An in vitro polysome display system for identifying ligands from very large peptide libraries

In vitro selection and evolution of functional proteins by using ribosome display

Expanding the genetic code for biological studies

RNA-peptide fusions for the in vitro selection of peptides and proteins

Towards synthesis of a minimal cell

Potent D-peptide inhibitors of HIV-1 entry

Covalent antibody display--an in vitro antibody-DNA library selection system

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

P304

431-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIP.22073

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23203688

http://www.w3.org/2001/XMLSchema#string

P932

3548907

http://www.w3.org/2001/XMLSchema#string